Evidence map›Paper›PMID 40432020›Full record

ArticleSensors (Basel, Switzerland)2025

An Ultra-Sensitive Colorimetric Sensing Platform for Simultaneous Detection of Moxifloxacin/Ciprofloxacin and Cr(III) Ions Based on Ammonium Thioglycolate Functionalized Gold Nanoparticles.

Lihua Zhang, Jiang Li, Juan Wang, Xu Yan, Jinping Song, Feng Feng

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lihua ZhangShanxi Provincial Key Laboratory of Chemical Biosensing, School of Chemistry and Chemical Engineering, Shanxi Datong University, Datong 037009, China.
Jiang LiShanxi Provincial Key Laboratory of Chemical Biosensing, School of Chemistry and Chemical Engineering, Shanxi Datong University, Datong 037009, China.ORCID 0000-0003-1928-6523
Juan WangShanxi Provincial Key Laboratory of Chemical Biosensing, School of Chemistry and Chemical Engineering, Shanxi Datong University, Datong 037009, China.
Xu YanShanxi Provincial Key Laboratory of Chemical Biosensing, School of Chemistry and Chemical Engineering, Shanxi Datong University, Datong 037009, China.
Jinping SongDepartment of Chemistry, Xinzhou Normal University, Xinzhou 034000, China.
Feng FengShanxi Provincial Key Laboratory of Chemical Biosensing, School of Chemistry and Chemical Engineering, Shanxi Datong University, Datong 037009, China.ORCID 0000-0002-0063-2724

Funding

Fundamental Research Program of Datong City 2023058Innovation and Entrepreneurship Training Program for College Students in Shanxi Province XDC2023121National Natural Science Foundation of China 22476118
6 · The paper itself

Abstract

Water pollution by antibiotics and heavy metals threatens the ecological environment and human health globally, yet there is no rapid method to detect multiple antibiotics and metal ions simultaneously. A simple, fast, and ultra-sensitive colorimetric chemosensor for the simultaneous detection of moxifloxacin (MOX), ciprofloxacin (CIP), and Cr(III) based on the aggregation of ammonium thioglycolate (ATG)-functionalized gold nanoparticles (ATG-AuNPs) was developed. Following the addition of MOX, CIP, and Cr(III), a color change in the solution was observed from wine-red to blue-grey. The UV-Vis signal of the ATG-AuNPs system blended with MOX, CIP, and Cr(III) in the range of 0~200 µM, 0~100 µM, and 0~5 µM was assessed and measured with detection limits (LODs) of 1.57 µM, 1.30 µM, and 57.1 nM calculated by 3σ/S, respectively. Therefore, this system has the potential to act as an effective colorimetric chemosensor for simultaneously detecting MOX, CIP, and Cr(III) in complex environmental systems.

Indexed as

ammonium thioglycolateciprofloxacin (CIP)colorimetric chemosensorCr(III)gold nanoparticlesmoxifloxacin (MOX)

Identifiers

PMID40432020
PMCPMC12116012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.